scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1001108882 |
P356 | DOI | 10.1007/S10616-012-9468-8 |
P932 | PMC publication ID | 3536879 |
P698 | PubMed publication ID | 22695857 |
P5875 | ResearchGate publication ID | 225305045 |
P2093 | author name string | Ken Takahashi | |
Hisaya Tanaka | |||
Toshiyuki Suzawa | |||
Yasufumi Imamoto | |||
Yoshinobu Konno | |||
P2860 | cites work | ywfE in Bacillus subtilis codes for a novel enzyme, L-amino acid ligase | Q24530582 |
Industrialization of mAb production technology: the bioprocessing industry at a crossroads | Q24655304 | ||
Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity | Q30835165 | ||
Development of a serum-free and heat-sterilizable medium and continuous high-density cell culture | Q35289438 | ||
Therapeutic antibodies--delivering the promise? | Q36528056 | ||
Non-fucosylated therapeutic antibodies: the next generation of therapeutic antibodies | Q37323537 | ||
Enhancement of antibody production by the addition of Coenzyme-Q(10). | Q39613088 | ||
Evaluation and optimization of hepatocyte culture media factors by design of experiments (DoE) methodology | Q39918228 | ||
Fermentative production of L-alanyl-L-glutamine by a metabolically engineered Escherichia coli strain expressing L-amino acid alpha-ligase | Q40006585 | ||
Antibody production | Q40258663 | ||
Comparison of cell lines for stable production of fucose-negative antibodies with enhanced ADCC. | Q40293476 | ||
Biopharmaceutical benchmarks 2006. | Q40307417 | ||
Preparation of silk protein sericin as mitogenic factor for better mammalian cell culture | Q40317555 | ||
The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity | Q40690773 | ||
Ammonia-induced apoptosis is accelerated at higher pH in gastric surface mucous cells | Q40704950 | ||
Adaptation of mammalian cells to non-ammoniagenic media. | Q41504935 | ||
Developement of serum-free media in CHO-DG44 cells using a central composite statistical design | Q42120435 | ||
Glutamine-based dipeptides are utilized in mammalian cell culture by extracellular hydrolysis catalyzed by a specific peptidase | Q42486241 | ||
P433 | issue | 1 | |
P921 | main subject | cell culture medium | Q108855608 |
P304 | page(s) | 135-143 | |
P577 | publication date | 2012-06-14 | |
P1433 | published in | Cytotechnology | Q15752151 |
P1476 | title | Advantages of AlaGln as an additive to cell culture medium: use with anti-CD20 chimeric antibody-producing POTELLIGENT™ CHO cell lines | |
P478 | volume | 65 |
Q34411764 | A comparison of the effects of oral glutamine dipeptide, glutamine, and alanine on blood amino acid availability in rats submitted to insulin-induced hypoglycemia |
Q98892821 | Increased MSX level improves biological productivity and production stability in multiple recombinant GS CHO cell lines |
Q99565391 | Investigation of cell line specific responses to pH inhomogeneity and consequences for process design |
Q90183215 | Production of adeno-associated virus vectors for in vitro and in vivo applications |
Q42407699 | Tracking dipeptides at work-uptake and intracellular fate in CHO culture |